Short Interest in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Rises By 180.0%

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 1,400 shares, a growth of 180.0% from the October 31st total of 500 shares. Based on an average daily trading volume, of 14,600 shares, the short-interest ratio is presently 0.1 days.

Institutional Trading of Tema Cardiovascular and Metabolics ETF

An institutional investor recently raised its position in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. lifted its position in shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 20.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 153,090 shares of the company’s stock after purchasing an additional 26,130 shares during the period. Tema Cardiovascular and Metabolics ETF accounts for about 1.4% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 20th biggest position. Sterling Investment Advisors Ltd. owned approximately 6.03% of Tema Cardiovascular and Metabolics ETF worth $5,104,000 at the end of the most recent reporting period.

Tema Cardiovascular and Metabolics ETF Stock Up 0.5 %

NASDAQ HRTS opened at $32.50 on Friday. Tema Cardiovascular and Metabolics ETF has a 52 week low of $26.62 and a 52 week high of $36.03. The business has a 50 day moving average price of $33.09 and a 200-day moving average price of $33.45. The company has a market cap of $80.60 million, a price-to-earnings ratio of 32.89 and a beta of 0.93.

Tema Cardiovascular and Metabolics ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.